Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has been given a consensus recommendation of “Buy” by the twelve research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on the stock in the […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target cut by equities research analysts at Jefferies Financial Group from $120.00 to $70.00 in a research report issued to clients and investors on Friday, The Fly reports. Jefferies Financial Group’s price objective points to a potential upside of 162.27% from the stock’s current price. A […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have received an average rating of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the stock in the […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a report issued on Tuesday, RTT News reports. They presently have a $51.00 price objective on the stock, down from their prior price objective of $71.00. Wedbush’s price objective would suggest a potential upside of 154.11% from […]